Cooperative role of the RNA-binding proteins Hzf and HuR in p53 activation

Molecular and Cellular Biology

Volumn 31, Issue 10, 2011, Pages 1997-2009

  Nakamura, Hideaki ^a   Kawagishi, Hiroyuki ^a   Watanabe, Atsushi ^a   Sugimoto, Kazushi ^b   Maruyama, Mitsuo ^a   Sugimoto, Masataka ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; HUR PROTEIN; MESSENGER RNA; PROTEIN MDM2; PROTEIN P19; PROTEIN P53; RNA BINDING PROTEIN; RNA BINDING PROTEIN HEMATOPOIETIC ZINC FINGER; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIGENS, SURFACE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FLUORESCENT ANTIBODY TECHNIQUE; GENES, P53; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; NIH 3T3 CELLS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79956115513     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01424-10     Document Type: Article

References (45)

1. Abdelmohsen, K., A. Lal, H. H. Kim, and M. Gorospe. 2007. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6:1288-1292.
2. Abdelmohsen, K., et al. 2009. Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J. 28:1271-1282.
3. Bachoo, R. M., et al. 2002. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1:269-277.
4. Bartek, J., and J. Lukas. 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-429.
5. Bertwistle, D., M. Sugimoto, and C. J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985-996.
6. Brennan, C. M., and J. A. Steitz. 2001. HuR and mRNA stability. Cell Mol. Life Sci. 58:266-277.
7. Das, S., et al. 2007. Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 130:624-637.
8. Galban, S., et al. 2003. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol. Cell. Biol. 23:7083-7095.
9. Gantt, K., J. Cherry, R. Tenney, V. Karschner, and P. H. Pekala. 2005. An early event in adipogenesis, the nuclear selection of the CCAAT enhancerbinding protein β (C/EBPβ) mRNA by HuR and its translocation to the cytosol. J. Biol. Chem. 280:24768-24774.
10. Good, P. J. 1995. A conserved family of elav-like genes in vertebrates. Proc. Natl. Acad. Sci. U. S. A. 92:4557-4561.
11. Hainaut, P., et al. 1998. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:205-213.
12. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
13. Hidaka, M., et al. 2000. Gene trapping of two novel genes, Hzf and Hhl, expressed in hematopoietic cells. Mech. Dev. 90:3-15.
14. Hinman, M. N., and H. Lou. 2008. Diverse molecular functions of Hu proteins. Cell Mol. Life Sci. 65:3168-3181.
15. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
16. Iijima, T., et al. 2005. Hzf protein regulates dendritic localization and BDNF-induced translation of type 1 inositol 1,4,5-trisphosphate receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 102:17190-17195.
17. Jin, A., K. Itahana, K. O'Keefe, and Y. Zhang. 2004. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24:7669-7680.
18. Kastan, M. B., and J. Bartek. 2004. Cell-cycle checkpoints and cancer. Nature 432:316-323.
19. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
20. Kastan, M. B., et al. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
21. Kawagishi, H., et al. 2008. Hzf regulates adipogenesis through translational control of C/EBPα. EMBO J. 27:1481-1490.
22. Kim, H. H., et al. 2008. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 22:1804-1815.
23. Kim, H. H., X. Yang, Y. Kuwano, and M. Gorospe. 2008. Modification at HuR(S242) alters HuR localization and proliferative influence. Cell Cycle 7:3371-3377.
24. Kimura, Y., et al. 2002. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J. Exp. Med. 195:941-952.
25. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
26. Kuo, M. L., et al. 2003. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res. 63:1046-1053.
27. Kurki, S., et al. 2004. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5:465-475.
28. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
29. Lohrum, M. A., R. L. Ludwig, M. H. Kubbutat, M. Hanlon, and K. H. Vousden. 2003. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3:577-587.
30. Lowe, S. W., and C. J. Sherr. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13:77-83.
31. Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144-8151.
32. Mazan-Mamczarz, K., et al. 2003. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc. Natl. Acad. Sci. U. S. A. 100:8354-8359.
33. Mosner, J., et al. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:4442-4449.
34. Nakamura, H., A. Asai, M. Maruyama, and M. Sugimoto. 2010. Production of rat monoclonal antibodies against RNA-binding protein Hzf. Hybridoma (Larchmt.) 29:7-11.
35. Prives, C. 1998. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5-8.
36. Schumacher, B., et al. 2005. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 120:357-368.
37. 2 phase checkpoint induced by DNA damage. Mol. Cell. Biol. 26:502-512.
38. Sugimoto, M., M. L. Kuo, M. F. Roussel, and C. J. Sherr. 2003. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11:415-424.
39. Takagi, M., M. J. Absalon, K. G. McLure, and M. B. Kastan. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123:49-63.
40. Takai, H., et al. 2002. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21:5195-5205.
41. Tong, X., and J. C. Pelling. 2009. Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR. Mol. Carcinog. 48:118-129.
42. Wang, W., X. Yang, V. J. Cristofalo, N. J. Holbrook, and M. Gorospe. 2001. Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol. Cell. Biol. 21:5889-5898.
43. Yuan, X., et al. 2005. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 19:77-87.
44. Zindy, F., et al. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424-2433.
45. Zou, T., et al. 2006. Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J. Biol. Chem. 281:19387-19394.